NORMAL SITUATION

GEBEPHARMA

Export PDF

Financial year 2025 · closed on 29/09/2025

Net result

-2,7 k €

-101.9% YoY

Gross margin

-9,3 k €

-104.8% YoY

Company — Normal situation.

What does GEBEPHARMA do?

GEBEPHARMA is a company registered in Belgium.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0432.124.508

Legal form

Private limited company

Latest accounts

29/09/2025

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	-9,3 k €	-105%	195,5 k €	+12188%	-1,6 k €	+27.3%	-2,2 k €	-19.8%	-1,9 k €	-101%	141,7 k €	+1339%	-11,4 k €	-104%	320,3 k €	+686%	40,7 k €	+13.7%	35,8 k €	-0.8%	36,1 k €	+12.0%	32,3 k €	-4.8%	33,9 k €	-1.4%	34,4 k €	-1.0%	34,7 k €	-3.2%	35,9 k €	+19.7%	30 k €	-9.5%	33,1 k €	+8.4%	30,6 k €	-1.8%	31,1 k €
EBITDA	-11,7 k €	-106%	194,2 k €	+6470%	-3 k €	+10.1%	-3,4 k €	-12.9%	-3 k €	-102%	137,9 k €	+1092%	-13,9 k €	-104%	317,9 k €	+729%	38,4 k €	+14.5%	33,5 k €	-1.2%	33,9 k €	+12.8%	30,1 k €	-5.2%	31,7 k €	-1.6%	32,2 k €	-1.3%	32,7 k €	-3.6%	33,9 k €	+21.1%	28 k €	-10.3%	31,2 k €	+8.8%	28,7 k €	-2.1%	29,3 k €
Operating result	-11,7 k €	-106%	194,2 k €	+3065%	-6,5 k €	+5.0%	-6,9 k €	-5.9%	-6,5 k €	-105%	134,1 k €	+798%	-19,2 k €	-106%	312,8 k €	+845%	33,1 k €	+17.6%	28,1 k €	-1.3%	28,5 k €	+15.7%	24,6 k €	-7.8%	26,7 k €	-2.8%	27,5 k €	-1.5%	27,9 k €	-4.2%	29,1 k €	+25.4%	23,2 k €	-10.4%	25,9 k €	+21.9%	21,3 k €	-2.7%	21,9 k €
Net result	-2,7 k €	-102%	143,5 k €	+4003%	-3,7 k €	+38.6%	-6 k €	-1.8%	-5,9 k €	-106%	96,1 k €	+612%	-18,8 k €	-106%	302,8 k €	+352%	67 k €	+318%	16 k €	+53.7%	10,4 k €	-25.6%	14 k €	-35.6%	21,7 k €	+1.2%	21,5 k €	-19.0%	26,5 k €	-10.0%	29,4 k €	+428%	5,6 k €	-33.6%	8,4 k €	+21.3%	6,9 k €	-26.9%	9,5 k €
Balance sheet
Equity	–		755,6 k €	+23.5%	612,1 k €	-0.6%	615,7 k €	-1.0%	621,7 k €	-0.9%	627,6 k €	+18.1%	531,5 k €	-3.4%	550,3 k €	+112%	259,4 k €	+19.3%	217,4 k €	+8.0%	201,4 k €	+5.5%	191 k €	+7.9%	177 k €	+14.0%	155,3 k €	+16.0%	133,8 k €	+24.7%	107,3 k €	+9.7%	97,9 k €	+0.6%	97,3 k €	+0.4%	96,9 k €	+0.4%	96,5 k €
Total assets	759,7 k €	+0.0%	759,5 k €	+23.6%	614,4 k €	-0.6%	618,2 k €	-1.0%	624,2 k €	-1.0%	630,5 k €	+15.4%	546,5 k €	-4.9%	574,6 k €	+24.8%	460,6 k €	+18.0%	390,2 k €	+4.0%	375,2 k €	+1.9%	368,3 k €	+5.2%	350,1 k €	+4.7%	334,5 k €	+6.6%	313,8 k €	+7.3%	292,5 k €	+10.4%	264,9 k €	+5.6%	250,7 k €	+7.9%	232,3 k €	+6.7%	217,6 k €
Cash	248,7 k €	+0.9%	246,6 k €	+125%	109,6 k €	+6.8%	102,6 k €	-3.0%	105,7 k €	-6.1%	112,5 k €	+4136%	2,7 k €	-99.2%	325 k €	+233%	97,7 k €	+243%	28,5 k €	+53.5%	18,6 k €	-85.0%	123,7 k €	+14.9%	107,7 k €	+1.4%	106,2 k €	+5.3%	100,9 k €	+5.8%	95,4 k €	+9.7%	86,9 k €	+248%	25 k €	+84.5%	13,5 k €	-69.3%	44,1 k €
Debts	756,2 k €	+19384%	3,9 k €	+64.3%	2,4 k €	-5.1%	2,5 k €	+0.5%	2,5 k €	-13.2%	2,9 k €	-81.0%	15,1 k €	-18.7%	18,5 k €	-90.6%	196,1 k €	+17.3%	167,2 k €	-0.2%	167,5 k €	-1.0%	169,2 k €	+2.9%	164,5 k €	-3.3%	170,1 k €	+0.1%	170 k €	-2.7%	174,7 k €	+14.8%	152,2 k €	+9.2%	139,3 k €	+12.6%	123,7 k €	+9.3%	113,1 k €

Governance

Board of directors

Seen on filing of 29/09/2025 · 1 active · 2 ended

Active mandates

Gerard DETRAIT

Director

Active

Ended mandates

Gérard DETRAIT

Manager

Ended

Gerard Michel Detrait

Administrator - manager

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	29/09/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	9 months	12 months	12 months	12 months	12 months	12 months
Filing date	27/10/2025	08/04/2025	18/06/2024	21/07/2023	20/06/2022	22/06/2021
General meeting	29/09/2025	31/03/2025	06/06/2024	01/06/2023	02/06/2022	03/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

38 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	29/09/2025	29/09/2025	27/10/2025	French	PDF
Micro model	31/12/2024	31/03/2025	08/04/2025	French	PDF
Micro model	31/12/2023	06/06/2024	18/06/2024	French	PDF
Micro model	31/12/2022	01/06/2023	21/07/2023	French	PDF
Micro model	31/12/2021	02/06/2022	20/06/2022	French	PDF
Micro model	31/12/2020	03/06/2021	22/06/2021	French	PDF
Micro model	31/12/2019	04/06/2020	29/07/2020	French	PDF
Micro model	31/12/2018	06/06/2019	02/07/2019	French	PDF
Abridged model	31/12/2017	07/06/2018	05/07/2018	French	PDF
Abridged model	31/12/2016	01/06/2017	08/06/2017	French	PDF
Abridged model	31/12/2015	02/06/2016	20/06/2016	French	PDF
Abridged model	31/12/2014	04/06/2015	31/08/2015	French	PDF
Abridged model	31/12/2013	27/06/2014	19/08/2014	French	PDF
Abridged model	31/12/2012	28/06/2013	01/07/2013	French	PDF
Abridged model	31/12/2011	30/06/2012	02/07/2012	French	PDF
Abridged model	31/12/2010	02/06/2011	08/06/2011	French	PDF
Abridged model	31/12/2009	09/06/2010	15/06/2010	French	PDF
Abridged model	31/12/2008	04/06/2009	08/06/2009	French	PDF
Abridged model	31/12/2007	26/05/2008	10/06/2008	French	PDF
Abridged model	31/12/2006	07/06/2007	18/06/2007	French	PDF
Abridged model	31/12/2005	08/06/2006	23/06/2006	French	PDF
Abridged model	31/12/2004	09/05/2005	25/05/2005	French	PDF
Abridged model	31/12/2003	03/06/2004	09/06/2004	French	PDF
Abridged model	31/12/2002	05/06/2003	06/06/2003	French	PDF

View all 38 filings

Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 29/09/2025 · 1 active · 2 ended

Active mandates

Gerard DETRAIT

Director

Active

Ended mandates

Gérard DETRAIT

Manager

Ended

Gerard Michel Detrait

Administrator - manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025-2,7 k €↓
2024
Annual accounts 2024143,5 k €↑
2023
Annual accounts 2023-3,7 k €↑
2022
Annual accounts 2022-6 k €↓
2021
Annual accounts 2021-5,9 k €↓
2020
Annual accounts 202096,1 k €↑
2019
Annual accounts 2019-18,8 k €↓
2018
Annual accounts 2018302,8 k €↑
2017
Annual accounts 201767 k €↑
2016
Annual accounts 201616 k €↑
2015
Annual accounts 201510,4 k €↓
2014
Annual accounts 201414 k €↓
2013
Annual accounts 201321,7 k €↑
2012
Annual accounts 201221,5 k €↓
2011
Annual accounts 201126,5 k €↓
2010
Annual accounts 201029,4 k €↑
2009
Annual accounts 20095,6 k €↓
2008
Annual accounts 20088,4 k €↑
2007
Annual accounts 20076,9 k €↓
2006
Annual accounts 20069,5 k €

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

GEBEPHARMA

Overview

What does GEBEPHARMA do?

Trend over 20 financial years

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Similar companies

Similar companies

Timeline